07:00 , May 14, 2012 |  BC Week In Review  |  Clinical News

Beposone: Phase II data

Top-line data from a double-blind, U.S. Phase II trial in about 600 patients aged 12 and older with allergic rhinitis due to Mountain Cedar pollen showed that twice-daily Beposone nasal spray significantly reduced total nasal...
08:00 , Feb 6, 2012 |  BC Week In Review  |  Clinical News

Beposone: Completed Phase II enrollment

Ista completed enrollment of more than 600 patients with allergic rhinitis due to Mountain Cedar pollen in a U.S. Phase II trial comparing twice-daily beposone nasal spray vs. a nasal spray of each of beposone's...
08:00 , Jan 9, 2012 |  BC Week In Review  |  Clinical News

Beposone: Phase II started

Ista began a U.S. Phase II trial to compare twice-daily beposone nasal spray vs. a nasal spray of each of beposone's components (bepotastine besilate and steroid) alone or placebo for 2 weeks in about 600...